The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Platelets impact the responsiveness of immune checkpoint blockade therapy in solid tumors.
 
Brian P Riesenberg
No Relationships to Disclose
 
Mingjia Li
No Relationships to Disclose
 
Daniel Spakowicz
No Relationships to Disclose
 
Rebecca Hoyd
No Relationships to Disclose
 
Joal Beane
Stock and Other Ownership Interests - Iovance Biotherapeutics
 
Yuanquan Yang
No Relationships to Disclose
 
Filiz Oezkan
Honoraria - Novartis
Consulting or Advisory Role - Epigenomics; Genentech/Roche
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - Nexus Pharmaceuticals Inc; Nexus Pharmaceuticals Inc
 
Kai He
Honoraria - Geneplus
Consulting or Advisory Role - Bristol-Myers Squibb; Mirati Therapeutics; Perthera
Research Funding - Adaptimmune (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Mirati Therapeutics (Inst)
 
Sandip H. Patel
No Relationships to Disclose
 
Andrew Johns
No Relationships to Disclose
 
Madison Grogan
No Relationships to Disclose
 
Abdul Miah
No Relationships to Disclose
 
Marium Husain
No Relationships to Disclose
 
Erin Marie Bertino
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Pfizer
 
Gregory Alan Otterson
Consulting or Advisory Role - Novartis; Novocure; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Kari Lynn Kendra
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Carolyn J Presley
Consulting or Advisory Role - PotentiaMetrics
Research Funding - Celgene (Inst)
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Biothera; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Helsinn Therapeutics; Incyte; Inivata; Loxo; Merck; Novartis; Peregrine Pharmaceuticals; Pfizer; Synta; Synta
Research Funding - Bristol-Myers Squibb
 
Zihai Li
Stock and Other Ownership Interests - Agenus (I); yuMed
Honoraria - Alphamab; Heat Biologics; Henlius
Consulting or Advisory Role - Alphamab; Heat Biologics; Henlius
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Have a patent on HSP vaccine technology that was license to Agenus
Travel, Accommodations, Expenses - henlius
 
Dwight Hall Owen
Consulting or Advisory Role - AstraZeneca; L&M Policy Research; theMednet
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Palobiofarma (Inst)
Travel, Accommodations, Expenses - AstraZeneca